Donor-to-Transplant Coordination Platform Director — Organ Network

The mandate

Donor hospitals, histocompatibility laboratories, allocation teams, transplant centres and transport partners maintain separate clocks and status vocabularies. Coordinators reconcile them by telephone during the most consequential hours. The network can report final allocation, yet struggles to explain whether suitability evidence, declined offers, consent restrictions, preservation time and transport feasibility were known to the right clinician at each decision point.

The commissioned deliverable is a Donor-to-Transplant Coordination Operating Architecture covering referral, identification, consent constraint, clinical assessment, sample, compatibility, offer sequence, acceptance, retrieval, packaging, transport, receipt and outcome feedback. Three representative organ pathways will be designed without encoding clinical or allocation judgement into opaque automation, and without exposing donor or recipient identity beyond authorised need.

By week four, milestone one provides observed journeys, clock reconciliation and a ranked catalogue of missed or delayed signals. Milestone two at week nine delivers the event model, responsibility matrix and downtime design. Week sixteen concludes controlled simulations; the final milestone at week twenty-two supplies accepted architecture, integration sequence, assurance cases and an internal exercise pack.

Acceptance requires clinical and coordination owners to reconstruct twelve unseen offer chains from referral through disposition, including reasons and effective timestamps; one cross-state transport disruption and one laboratory correction must be handled without consultant direction; and Privacy and Ethics must approve identity separation. The medical director signs after accountable clinicians validate that automation never substitutes eligibility or allocation judgement.

The client will provide de-identified referral and offer histories, approved allocation rules, consent restrictions, laboratory messages, theatre and transport events, incident reviews, supplier terms and downtime procedures. Named coordinators, transplant clinicians, ethicists and privacy officers will join workshops. Client engineers build references and resolve interfaces; hospitals remain responsible for clinical records, staffing and bedside practice.

Why this is external work

Each organisation can improve its own system, but failures often occur between an emerging donor fact and the next party’s time-sensitive decision. Vendors optimise messages rather than clinical accountability. An independent design authority can expose cross-network delay and evidence gaps while leaving consent, suitability, allocation and acceptance with legally authorised professionals.

What you will own

• Trace donor referral, assessment, consent constraint, sample, compatibility, allocation sequence, offer response, retrieval, transport and receipt events.
• Reconcile clinical, laboratory, allocation, preservation and logistics clocks without manufacturing precision where source time is uncertain.
• Design minimum-necessary identity boundaries linking episodes safely while preventing unnecessary donor-recipient or cross-centre disclosure.
• Exercise corrected laboratory result, unreachable centre, conditional acceptance, aircraft delay, preservation breach and simultaneous multi-organ retrieval.
• Specify acknowledgement, escalation, reason capture and immutable correction duties for every inter-organisational hand-off.
• Compare integration approaches through clinical latency, downtime tolerance, explainability, security, supplier exit and total operating burden.
• Transfer scenario authorship, evidence review and pathway assurance to permanent clinical, coordination and technology owners.

Candidate qualifications

• Directed national or multi-state transplant, blood, emergency-care or similarly time-critical clinical coordination platforms in live service.
• Understood donation referral, compatibility evidence, offer sequencing, preservation constraints and clinical acceptance sufficiently to protect professional boundaries.
• Reconstructed consequential cross-organisation decisions from mismatched clinical, laboratory, allocation and transport clocks under external scrutiny.
• Designed privacy separation for highly sensitive linked episodes while preserving authorised traceability and post-event clinical review.
• Led simulations in which transport disruption, corrected results or unreachable teams forced rapid, documented pathway decisions.
• Delivered vendor-neutral clinical operating architecture that internal teams implemented and exercised after external specialists withdrew.

Non-negotiables

• The named director must lead São Paulo pathway observation and both cross-network acceptance simulations in person.
• No financial attachment may exist with allocation, laboratory, electronic-record or transport suppliers assessed in the engagement.
• Consent, donor suitability, organ allocation and recipient acceptance remain solely with authorised clinical and public bodies.
• Identifiable donor and recipient evidence cannot leave approved environments or be reused as consultancy reference material.

1. 49 words maximum. Describe a time-critical donor or clinical pathway where conflicting clocks changed the safe coordination decision.
2. 49 words maximum. How did you preserve offer-chain explainability without automating accountable allocation or acceptance judgement?
3. 49 words maximum. Which client evidence must exist before a corrected-laboratory-result simulation can be accepted?